Payment overview · 2025
General Payments
$44.84
2 reported records · 1 companies
Healthcare provider profile · identity verified
Peter Steve Maurides, MD, FACP
Allopathic & Osteopathic Physicians|Internal Medicine · GREENVILLE, SC · NPI 1649255472
Verified facts
What the public records show
CMS Open Payments records show Peter Steve Maurides, MD, FACP received $44.84 in general payments during 2025 across 2 reported records.
Boston Scientific Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $44.84 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $44.84 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BodyGuardian Normalized: bodyguardian |
Device | Boston Scientific Corporation | $44.84 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Omeprazole | Omeprazole | 532 | 160 |
| Atorvastatin Calcium | Atorvastatin Calcium | 478 | 149 |
| Levothyroxine Sodium | Levothyroxine Sodium | 470 | 126 |
| Losartan Potassium | Losartan Potassium | 387 | 120 |
| Pantoprazole Sodium | Pantoprazole Sodium | 374 | 111 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 328 | 93 |
| Amlodipine Besylate | Amlodipine Besylate | 299 | 87 |
| Hydrochlorothiazide | Hydrochlorothiazide | 283 | 88 |
| Tamsulosin Hcl | Tamsulosin Hcl | 255 | 74 |
| Potassium Chloride | Potassium Chloride | 253 | 73 |
| Montelukast Sodium | Montelukast Sodium | 251 | 72 |
| Fluticasone Propionate | Fluticasone Propionate | 245 | 100 |
| Escitalopram Oxalate | Escitalopram Oxalate | 235 | 66 |
| Eliquis | Apixaban | 231 | 42 |
| Celecoxib | Celecoxib | 223 | 74 |
| Simvastatin | Simvastatin | 220 | 59 |
| Lorazepam | Lorazepam | 216 | 56 |
| Sertraline Hcl | Sertraline Hcl | 198 | 58 |
| Gabapentin | Gabapentin | 192 | 52 |
| Metoprolol Succinate | Metoprolol Succinate | 188 | 54 |
| Irbesartan | Irbesartan | 180 | 50 |
| Lisinopril | Lisinopril | 179 | 46 |
| Duloxetine Hcl | Duloxetine Hcl | 176 | 42 |
| Pravastatin Sodium | Pravastatin Sodium | 169 | 51 |
| Ezetimibe | Ezetimibe | 164 | 50 |
| Metformin Hcl Er | Metformin Hcl | 162 | 48 |
| Clonazepam | Clonazepam | 160 | 28 |
| Meloxicam | Meloxicam | 148 | 53 |
| Bupropion Xl | Bupropion Hcl | 141 | 36 |
| Famotidine | Famotidine | 131 | 40 |
| Finasteride | Finasteride | 129 | 39 |
| Trazodone Hcl | Trazodone Hcl | 125 | 37 |
| Carvedilol | Carvedilol | 122 | 36 |
| Allopurinol | Allopurinol | 121 | 32 |
| Jardiance | Empagliflozin | 115 | 27 |
| Alendronate Sodium | Alendronate Sodium | 114 | 33 |
| Estradiol | Estradiol | 113 | 43 |
| Furosemide | Furosemide | 112 | 35 |
| Ozempic | Semaglutide | 106 | 17 |
| Alprazolam | Alprazolam | 99 | 26 |
| Glimepiride | Glimepiride | 97 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 94 | 28 |
| Metformin Hcl | Metformin Hcl | 93 | 25 |
| Tramadol Hcl | Tramadol Hcl | 92 | 28 |
| Spironolactone | Spironolactone | 90 | 30 |
| Donepezil Hcl | Donepezil Hcl | 87 | 20 |
| Metoprolol Tartrate | Metoprolol Tartrate | 87 | 25 |
| Diclofenac Sodium | Diclofenac Sodium | 85 | 31 |
| Methylprednisolone | Methylprednisolone | 84 | 75 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 75 | 31 |
| Januvia | Sitagliptin Phosphate | 72 | 11 |
| Pregabalin | Pregabalin | 69 | 18 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 67 | 26 |
| Ramipril | Ramipril | 64 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 63 | 20 |
| Prednisone | Prednisone | 63 | 27 |
| Mirtazapine | Mirtazapine | 62 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 60 | 17 |
| Lovastatin | Lovastatin | 57 | 15 |
| Synthroid | Levothyroxine Sodium | 56 | 15 |
| Valsartan | Valsartan | 54 | 16 |
| Myrbetriq | Mirabegron | 53 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 53 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 49 | 12 |
| Xarelto | Rivaroxaban | 47 | 12 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 42 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 42 | 39 |
| Fluoxetine Hcl | Fluoxetine Hcl | 42 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 42 | 12 |
| Torsemide | Torsemide | 42 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | suppressed |
| Ketoconazole | Ketoconazole | 38 | 17 |
| Raloxifene Hcl | Raloxifene Hcl | 38 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 37 | suppressed |
| Nitroglycerin | Nitroglycerin | 37 | 24 |
| Nystatin | Nystatin | 37 | 18 |
| Bupropion Hcl Sr | Bupropion Hcl | 36 | 13 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 35 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 35 | 26 |
| Repatha Sureclick | Evolocumab | 35 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 34 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 34 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 34 | 11 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 34 | suppressed |
| Azithromycin | Azithromycin | 33 | 32 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | 11 |
| Farxiga | Dapagliflozin Propanediol | 31 | suppressed |
| Fluconazole | Fluconazole | 30 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 30 | suppressed |
| Acyclovir | Acyclovir | 29 | 11 |
| Fenofibrate | Fenofibrate | 28 | suppressed |
| Rivastigmine | Rivastigmine | 28 | suppressed |
| Atenolol | Atenolol | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 18 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | 11 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Naproxen | Naproxen | 25 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 24 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 24 | suppressed |
| Tradjenta | Linagliptin | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 22 |
| Arnuity Ellipta | Fluticasone Furoate | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 23 | 12 |
| Midodrine Hcl | Midodrine Hcl | 23 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 22 | suppressed |
| Levetiracetam | Levetiracetam | 22 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 21 | 17 |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Trulicity | Dulaglutide | 21 | suppressed |
| Zaleplon | Zaleplon | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 13 |
| Mounjaro | Tirzepatide | 20 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 20 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Premarin | Estrogens, Conjugated | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 12 |
| Galantamine Er | Galantamine Hbr | 18 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 18 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 18 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | suppressed |
| Klor-Con M10 | Potassium Chloride | 17 | suppressed |
| Klor-Con M20 | Potassium Chloride | 17 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Cilostazol | Cilostazol | 16 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Levoxyl | Levothyroxine Sodium | 16 | suppressed |
| Praluent Pen | Alirocumab | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 15 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 15 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 15 |
| Pitavastatin Calcium | Pitavastatin Calcium | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Droxidopa | Droxidopa | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Cefadroxil | Cefadroxil | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Emtricitabine-Tenofovir Disop | Emtricitabine/Tenofovir (Tdf) | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 12 | suppressed |
| Toprol Xl | Metoprolol Succinate | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 11 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Dotti | Estradiol | 11 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Travoprost | Travoprost | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $44.84 · 2 records | Boston Scientific Corporation | BodyGuardian | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error